These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27771436)

  • 1. Clinical potential of oligonucleotide-based therapeutics in the respiratory system.
    Moschos SA; Usher L; Lindsay MA
    Pharmacol Ther; 2017 Jan; 169():83-103. PubMed ID: 27771436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver as a target for oligonucleotide therapeutics.
    Sehgal A; Vaishnaw A; Fitzgerald K
    J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligonucleotide delivery: a patent review (2010 - 2013).
    Grijalvo S; Aviñó A; Eritja R
    Expert Opin Ther Pat; 2014 Jul; 24(7):801-19. PubMed ID: 24798406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNAi for Developing Targeted Therapeutics--CHI's Third Annual Meeting.
    Plane G
    IDrugs; 2010 Jan; 13(1):20-2. PubMed ID: 20024842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-coding RNAs: Therapeutic Strategies and Delivery Systems.
    Ling H
    Adv Exp Med Biol; 2016; 937():229-37. PubMed ID: 27573903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted electro-delivery of oligonucleotides for RNA interference: siRNA and antimiR.
    Chabot S; Teissié J; Golzio M
    Adv Drug Deliv Rev; 2015 Jan; 81():161-8. PubMed ID: 24819217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of Antisense Drugs.
    Bennett CF; Baker BF; Pham N; Swayze E; Geary RS
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():81-105. PubMed ID: 27732800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Pharmacology of RNA Interference-Based Therapeutics: A Summary Based on Food and Drug Administration-Approved Small Interfering RNAs.
    Jing X; Arya V; Reynolds KS; Rogers H
    Drug Metab Dispos; 2023 Feb; 51(2):193-198. PubMed ID: 36332914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achieving successful delivery of oligonucleotides--From physico-chemical characterization to in vivo evaluation.
    Scomparin A; Polyak D; Krivitsky A; Satchi-Fainaro R
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1294-309. PubMed ID: 25916823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting long non-coding RNAs in cancers: progress and prospects.
    Li CH; Chen Y
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1895-910. PubMed ID: 23748105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Clicking" Gene Therapeutics: A Successful Union of Chemistry and Biomedicine for New Solutions.
    Astakhova K; Ray R; Taskova M; Uhd J; Carstens A; Morris K
    Mol Pharm; 2018 Aug; 15(8):2892-2899. PubMed ID: 29300491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress toward oligonucleotide therapeutics: pharmacodynamic properties.
    Crooke ST
    FASEB J; 1993 Apr; 7(6):533-9. PubMed ID: 7682523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development.
    Andersson S; Antonsson M; Elebring M; Jansson-Löfmark R; Weidolf L
    Drug Discov Today; 2018 Oct; 23(10):1733-1745. PubMed ID: 29852223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can colorectal delivery technology provide a platform for enteral oligonucleotide-based therapeutics?
    Murakami M; Watanabe C
    Drug Discov Ther; 2016; 10(5):273-275. PubMed ID: 27890901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent preclinical and clinical advances in oligonucleotide conjugates.
    Craig K; Abrams M; Amiji M
    Expert Opin Drug Deliv; 2018 Jun; 15(6):629-640. PubMed ID: 29727206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs (review).
    Hope MJ; Mui B; Ansell S; Ahkong QF
    Mol Membr Biol; 1998; 15(1):1-14. PubMed ID: 9595549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligonucleotide therapeutics: chemistry, delivery and clinical progress.
    Sharma VK; Watts JK
    Future Med Chem; 2015; 7(16):2221-42. PubMed ID: 26510815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splice-switching antisense oligonucleotides as therapeutic drugs.
    Havens MA; Hastings ML
    Nucleic Acids Res; 2016 Aug; 44(14):6549-63. PubMed ID: 27288447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleic Acid-Based Therapeutics for Pulmonary Diseases.
    Chen J; Tang Y; Liu Y; Dou Y
    AAPS PharmSciTech; 2018 Nov; 19(8):3670-3680. PubMed ID: 30338490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splice-switching efficiency and specificity for oligonucleotides with locked nucleic acid monomers.
    Guterstam P; Lindgren M; Johansson H; Tedebark U; Wengel J; El Andaloussi S; Langel U
    Biochem J; 2008 Jun; 412(2):307-13. PubMed ID: 18271753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.